Shenzhen Hepalink Pharmaceutical Group has patented a pharmaceutical composition combining berberine with organic acids for treating various diseases. The composition can address conditions like diabetes, obesity, heart diseases, and liver disorders. The invention aims to improve liver function in chronic viral and alcohol-related liver diseases. GlobalData’s report on Shenzhen Hepalink Pharmaceutical Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Shenzhen Hepalink Pharmaceutical Group, Transgenic murine models was a key innovation area identified from patents. Shenzhen Hepalink Pharmaceutical Group's grant share as of May 2024 was 48%. Grant share is based on the ratio of number of grants to total number of patents.
Berberine compositions for treating various diseases
A recently granted patent (Publication Number: US11976063B2) discloses a pharmaceutical composition containing berberine and various therapeutic agents like benfotiamine, chromium picolinate, and vitamins A, B12, C, D, and E. This composition is designed to treat a range of diseases and disorders including atherosclerosis, cancer, inflammation, muscle atrophy, heart disease, liver disease, metabolic disorders, and neurodegenerative diseases.
Moreover, the patent also covers a kit comprising the pharmaceutical composition along with instructions for administering it to mammals suffering from the mentioned diseases. The method outlined in the patent involves administering the pharmaceutical composition to treat diseases like atherosclerosis, heart disease, metabolic disorders such as diabetes, dyslipidemia, fatty liver disease, and conditions like obesity and prediabetes. The patent provides a comprehensive approach to addressing various health issues through the use of the disclosed pharmaceutical composition and additional therapeutic agents.
To know more about GlobalData’s detailed insights on Shenzhen Hepalink Pharmaceutical Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
